Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Lyakhovich

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 21, 2020
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumoniaGiovanni Pagano, Carla Manfredi, Federico V Pallardó, et al.
Antioxidants (Basel, Switzerland)|January 23, 2020
Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial DysfunctionGiovanni Pagano, Federico V Pallardó, Beatriz Porto, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|February 14, 2025
Antibacterials exert toxic effects on aquatic organisms by inhibiting respiration, inducing oxidative stress, mitochondrial dysfunction and autophagyHagar Fadda, Raheema Hassan Khan, Yara Shqair, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 26, 2020
Friedreich Ataxia: current state-of-the-art, and future prospects for mitochondrial-focused therapiesFederico V Pallardó, Giovanni Pagano, Laura R Rodríguez, et al.
International Journal of Molecular Sciences|September 30, 2020
Aging-Related Disorders and Mitochondrial Dysfunction: A Critical Review for Prospect Mitoprotective Strategies Based on Mitochondrial Nutrient MixturesGiovanni Pagano, Federico V Pallardó, Alex Lyakhovich, et al.
Inflammopharmacology|December 10, 2024
Prooxidant state in anticancer drugs and prospect use of mitochondrial cofactors and anti-inflammatory agents in cancer preventionGiovanni Pagano, Alex Lyakhovich, Philippe J Thomas, et al.
Genome Integrity|February 15, 2011
Fanconi anemia protein FANCD2 inhibits TRF1 polyADP-ribosylation through tankyrase1-dependent mannerAlex Lyakhovich, Maria Jose Ramirez, Andres Castellanos, et al.
Biological Reviews of the Cambridge Philosophical Society|May 3, 2017
The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapyJuan Lorente, Carolina Velandia, Jose A Leal, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Toward Mitochondrial Targeting of Resistant Triple-Negative Breast Cancer Using Triphenylphosphonium-Conjugated Antimicrobial PeptidesEda Kapan, Cemile Uslu, Haya Arab, et al.
Redox Biology|January 14, 2021
Re-definition and supporting evidence toward Fanconi Anemia as a mitochondrial disease: Prospects for new design in clinical managementGiovanni Pagano, Luca Tiano, Federico V Pallardó, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 21, 2020
Potential roles of mitochondrial cofactors in the adjuvant mitigation of proinflammatory acute infections, as in the case of sepsis and COVID-19 pneumoniaGiovanni Pagano, Carla Manfredi, Federico V Pallardó, et al.
Antioxidants (Basel, Switzerland)|January 23, 2020
Mitoprotective Clinical Strategies in Type 2 Diabetes and Fanconi Anemia Patients: Suggestions for Clinical Management of Mitochondrial DysfunctionGiovanni Pagano, Federico V Pallardó, Beatriz Porto, et al.
Aquatic Toxicology (Amsterdam, Netherlands)|February 14, 2025
Antibacterials exert toxic effects on aquatic organisms by inhibiting respiration, inducing oxidative stress, mitochondrial dysfunction and autophagyHagar Fadda, Raheema Hassan Khan, Yara Shqair, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 26, 2020
Friedreich Ataxia: current state-of-the-art, and future prospects for mitochondrial-focused therapiesFederico V Pallardó, Giovanni Pagano, Laura R Rodríguez, et al.
International Journal of Molecular Sciences|September 30, 2020
Aging-Related Disorders and Mitochondrial Dysfunction: A Critical Review for Prospect Mitoprotective Strategies Based on Mitochondrial Nutrient MixturesGiovanni Pagano, Federico V Pallardó, Alex Lyakhovich, et al.
Inflammopharmacology|December 10, 2024
Prooxidant state in anticancer drugs and prospect use of mitochondrial cofactors and anti-inflammatory agents in cancer preventionGiovanni Pagano, Alex Lyakhovich, Philippe J Thomas, et al.
Genome Integrity|February 15, 2011
Fanconi anemia protein FANCD2 inhibits TRF1 polyADP-ribosylation through tankyrase1-dependent mannerAlex Lyakhovich, Maria Jose Ramirez, Andres Castellanos, et al.
Biological Reviews of the Cambridge Philosophical Society|May 3, 2017
The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapyJuan Lorente, Carolina Velandia, Jose A Leal, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Toward Mitochondrial Targeting of Resistant Triple-Negative Breast Cancer Using Triphenylphosphonium-Conjugated Antimicrobial PeptidesEda Kapan, Cemile Uslu, Haya Arab, et al.
Redox Biology|January 14, 2021
Re-definition and supporting evidence toward Fanconi Anemia as a mitochondrial disease: Prospects for new design in clinical managementGiovanni Pagano, Luca Tiano, Federico V Pallardó, et al.
Pageof 5